Lumens Biosciences Acquires Management Rights of Polaris Uno
Predicted impact: Medium
Acquisition of Polaris Uno management rights worth about ₩57.3B, versus a small market value; repeat of prior reports.
038060 · KOSDAQ · ₩038060 · 루멘스바이오스
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−76.2% from the high
₩985Today: ₩985 – ₩1,027₩4,200
Returns
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals describe activity, not recommendations. Not financial advice.
Lumens Bios (루멘스바이오스, KRX: 038060) is listed on KOSDAQ, in the Semiconductors sector. Lumens operates through its subsidiaries in three business segments: LED, LGP (light guide plates), and automotive electronics. Its shares closed at ₩1,001 on Oct 27, 2026, up 0.81% on the day, giving it a market value of ₩26B.
Lumens operates through its subsidiaries in three business segments: LED, LGP (light guide plates), and automotive electronics. Its LED segment supplies LED chips and modules for LCD TV backlights and general lighting, and its LGP segment makes light guide plates for TVs, lighting and automobiles. The automotive electronics segment produces LED modules and related modules for car headlamps and daytime running lights, and its manufacturing is largely carried out by subsidiaries in China and Vietnam.
Written by AI from the company's latest annual report.
Predicted impact: Medium
Acquisition of Polaris Uno management rights worth about ₩57.3B, versus a small market value; repeat of prior reports.
Predicted impact: Medium
Acquisition of ₩57.3B stake for 34%, about 199% of market value of ₩28.8B for the buyer.
High impactPredicted impact: High
Acquiring 13.8B won of shares, about 47% of the company's 29.6B won market value.
Titles in Korean until English translations are added.
Also known as: Lumens Bios / 루멘스바이오스 / 038060 / KRX:038060
Source: KRX statistical information